I asked a question in the investor hub, and this is the...

I asked a question in the investor hub, and this is the responses. Answers nothing. I am an investor and want RECCE to succeed as I believe they have a good product. I know it will work, but the timeline is very long. I feel there needs to be more communication.

Question- When do you expect to start the phase 1 trial, and when do you expect results to be published. Do you have enough money for this trial and phase 2 trial, or do you expect to raise capital by releasing more shares in the next 6 months.

Answer- Hi Sam,Thank you for getting in touch via our Investor Hub. The Company has recently received Human Research Ethics Approval to begin our Phase I/II Clinical Trial, the Phase I element of this trial will look at assessing R327 as an intravenous dose at faster infusion rates with an expected data read out of Q3CY23. Regarding funding for future trials, the Company released its Quarterly 4C report last week and has a cash balance at time of announcement (28 April 2023) of $4.61m and anticipates an additional non-dilutionary R&D Rebate in near weeks. DisclaimerRecce Pharmaceuticals Ltd makes no warranties or representations (expressed or implied) regarding the accuracy or completeness of the information arising out of, contained in or derived from this response. Certain statements made may contain forward looking statements, which involve known and unknown risk, uncertainties and other factors, which may cause the actual results or performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements